Raymond James Financial Services Advisors’s VistaGen Therapeutics VTGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-358
Closed -$13K 3342
2022
Q1
$13K Buy
+358
New +$13K ﹤0.01% 3234